Last reviewed · How we verify
Vicagrel Capsules
At a glance
| Generic name | Vicagrel Capsules |
|---|---|
| Sponsor | Jiangsu vcare pharmaceutical technology co., LTD |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Pharmacokinetic/Pharmacodynamic Study of Vicagrel Capsules and Clopidogrel Tablets in Healthy CYP2C19 Normal Metabolizers (PHASE1)
- PK/PD Study of Vicagrel and Clopidogrel in Healthy Subjects With Different CYP2C19 Metabolizers (PHASE1)
- Assessment of the Effect of Omeprazole on Vicagrel in Healthy Subjects (PHASE1)
- A Clinical Trial to Evaluate the Effect of Food on PK and PD of Vicagrel Capsules in Healthy Adult Subjects (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Vicagrel Capsules CI brief — competitive landscape report
- Vicagrel Capsules updates RSS · CI watch RSS
- Jiangsu vcare pharmaceutical technology co., LTD portfolio CI